The influence of race and language on chronic hepatitis C virus infection management

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 2, 2009, Pages 131-136

  Giordano, Céline ^a   Cooper, Curtis ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Data synthesis; Ethnicity; Hepatitis C virus, knowledge transfer, language, race, treatment access

Indexed keywords

PEGINTERFERON; RIBAVIRIN; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; DOCTOR PATIENT RELATION; DRUG POTENTIATION; ETHNICITY; HEALTH CARE DELIVERY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INTERPRETER SERVICE; LANGUAGE; PHYSICIAN; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RACE; REVIEW; RISK FACTOR; TRADITIONAL MEDICINE; ETHNOLOGY; HEPATITIS C, CHRONIC; MASS SCREENING; STANDARDS; UTILIZATION;

ANTIVIRAL AGENTS; DELIVERY OF HEALTH CARE; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C, CHRONIC; HUMANS; LANGUAGE; MASS SCREENING; MEDICINE, TRADITIONAL; PHYSICIAN-PATIENT RELATIONS;

EID: 59149100682     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32830b387b     Document Type: Review

References (59)

1. Weekly Epidemiological Record. World Health Organization Monograph Series 1999; 74:421-428.
2. World Heath Organization. Hepatitis C Factsheet No. 164.
3. Metha SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, et al. Protection against persistence of hepatitis C. Lancet. 2002; 359:1478-1483.
4. Celona AF, Yu MC, Prakash M, Kuo T, Bonacini M. Hepatitis C in a Los Angeles public hepatitis clinic: demographic and biochemical differences associated with race-ethnicity. Clin Gastroenterol Hepatol 2004; 2:459-462.
5. Bonacini M, Groshen MD, Yu MC, Govindarajan S, Lindsay KL. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol 2001; 96:2438-2441.
6. Gupta K, Romney D, Briggs M, Benker K. Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals. J Community Health 2007; 32:221-230.
7. Stevenson L, Faucher Y, Hewlett S, Klemm K, Nelson D. Chronic hepatitis C virus and the Hispanic community: cultural factors impacting care. Gastroenterol Nurs 2004; 27:230-238.
8. Dev AT, McCaw R, Sundararajan V, Bowden S, Sievert W. Southeast Asian patients with chronic hepatitis C: the impact of novel genotypes and race on treatment outcome. Hepatology 2002; 36:1259-1265.
9. Walley AY, White MC, Kushel MB, Song YS, Tulsky JP. Knowledge of and interest in hepatitis C treatment at a methadone clinic. J Subst Abuse Treat 2005; 28:181-187.
10. Dev A, Sundararajan V, Sievert W. Ethnic and cultural determinants influence risk assessment for hepatitis C acquisition. J Gastroenterol Hepatol 2004; 19:792-798.
11. Dev A, Sievert W. A survey of Australian general practice management of hepatitis C-infected patients from non-English-speaking backgrounds. J Gastroenterol Hepatol 2002; 17:295-300.
12. Weigand K, Stremmel W, Encke J. Treatment of hepatitis C virus infection. World J Gastroenterol 2007; 13:1897-1905.
13. Firpi RJ, Nelson DR. Current and future hepatitis C therapies. Arch Med Res 2007; 38:678-690.
14. Jeffers U. Treating hepatitis C in African Americans. Liver Int 2007; 27:313-322.
15. Conjeevaram HS, Fried MW, Jeffers U, Terrault NA, Wiley-Lucas TE, Afdhal N, et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006; 131:470-477.
16. McHutchison JG, Poynard T, Pianko S, Gordon SC, Reid AE, Dienstag J, et a/. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group. Gastroenterology 2000; 119:1317-1323.
17. Reddy KR, Hoofnagle JH, Tong MJ, Lee WM, Pockros P, Heathcote EJ, et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology 1999; 30: 787-793.
18. Cheung RC, Currie S, Shen H, Ho SB, Bini EJ, Anand BS, et al. Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. Am J Gastroenterol 2005; 100:2186-2193.
19. Hepburn MJ, Hepburn LM, Cantu NS, Lapeer MG, Lawitz EJ. Differences in treatment outcome for hepatitis C among ethnic groups. Am J Med 2004; 117:163-168.
20. Balfour L, Cooper C, Tasca GA, Kane M, Kowal J, Garber G. Evaluation of health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based, viral hepatitis clinic. Can J Public Health 2004; 95:272-277.
21. Steele LS, Glazier RH, Lin E. Inequity in mental health care under Canadian universal health coverage. Psychiatr Serv 2006; 57:317-324.
22. Thomicroft G. Stigma and discrimination limit access to mental health care. Epidemiol Psichiatr Soc 2008; 17:14-19.
23. Watson B, Conigrave KM, Wallace C, Whitfield JB, Wurst F, Haber PS. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug Alcohol Rev 2007; 26:231-239.
24. Sadavoy J, Meier R, Ong AY. Barriers to access to mental health services for ethnic seniors: the Toronto study. Can J Psychiatry 2004; 49:192-199.
25. Wynaden D, Chapman R, Orb A, McGowan S, Zeeman Z, Yeak S. Factors that influence Asian communities' access to mental health care. Int J Ment Health Nurs 2005; 14:88-95.
26. Larson CO, Schlundt D, Patel K, McClellan L, Hargreaves M. Disparities in perceptions of healthcare access in a community sample. J Ambul Care Manage 2007; 30:142-149.
27. Finkelstein MM. Do factors other than need determine utilization of physicians' services in Ontario? Can Med Assoc J 2001; 165:565-570.
28. Liu R, So L, Quan H. Chinese and white Canadian satisfaction and compliance with physicians. BMC Fam Pract 2007; 8:11.
29. Quan H, Fong A, De Coster C, Wang J, Musto R, Noseworthy TW, et al. Variation in health services utilization among ethnic populations. C Med Assoc J 2006; 174:787-791.
30. Dunlop S, Coyte PC, Mclsaac W. Socio-economic status and the utilization of physicians' services: results from the Canadian National Population Health Survey. Soc Sci Med 2000; 51:123-133.
31. Nabalamba A, Millar WJ. Going to the doctor. Health Rep 2007; 18: 23-35.
32. Haider A, Mamdani M, Shaw JC, Alter DA, Shear NH. Socioeconomic status influences care of patients with acne in Ontario, Canada. J Am Acad Dermatol 2006; 54:331-335.
33. Weech-Maldonado R, Morales LS, Elliott M, Spritzer K, Marshall G, Hays RD. Race/ethnicity, language, and patients' assessments of care in Medicaid managed care. Health Serv Res 2003; 38:789-808.
34. Bliss EB, Meyers DS, Phillips RL Jr, Fryer GE, Dovey SM, Green LA. Variation in participation in health care settings associated with race and ethnicity. J Gen Intern Med 2004; 19:931-936.
35. Butt AA, Justice AC, Skanderson M, Rigsby MO, Good CB, Kwoh CK. Rate and predictors of treatment prescription for hepatitis C. Gut 2007; 56:385-389.
36. Wen SW, Goel V, Williams Jl. Utilization of health care services by immigrants and other ethnic/cultural groups in Ontario. Ethn Health 1996; 1:99-109.
37. Kirmayer U, Weinfeld M, Burgos G, Du Fort GG, Lasry JC, Young A. Use of health care services for psychological distress by immigrants in an urban multicultural milieu. Can J Psychiatry 2007; 52:295-304.
38. Talbot Y, Fuller-Thomson E, Tudiver F, Habib Y, Mclsaac WJ. Canadians without regular medical doctors. Who are they? Can Fam Physician 2001; 47:58-64.
39. Kennedy J, Morgan S. A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health. Clin Ther 2006; 28:1217-1224.
40. Shehab TM, Orrego M, Chunduri R, Lok AS. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol 2003; 98:639-644.
41. Trooskin SB, Navarro VJ, Winn RJ, Axelrod DJ, McNeal AS, Velez M, et al. Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity. World J Gastroenterol 2007; 13:1074-1078.
42. D'Souza RF, Glynn MJ, Alstead E, Osonayo C, Foster GR. Knowledge of chronic hepatitis C among East London primary care physicians following the Department of Health's educational campaign. Q J Med 2004; 97:331-336.
43. Navarro VJ, St Louis TE, Bell BP. Identification of patients with hepatitis C virus infection in New Haven County primary care practices. J Clin Gastroenterol 2003; 36:431-435.
44. Smith BJ, Bauman AE, Chen J, Loveday S, Costello M, Mackie B, et al. Hepatitis C in Australia: impact of a mass media campaign. Am J Prev Med 2006; 31:492-498.
45. Zdanuk S, Gimpel J, Uhanova J, Kaita KD, Minuk GY. The impact of medical informatics on the confidence of rural physicians caring for patients with chronic hepatitis C viral infections. Fam Pract 2001; 18:602-604.
46. Sahajian F, Excler G, Bailly F, Caillat-Vallet E, Trepo C, Sepetjan M, et al. Hepatitis C screening practices among private practitioners: impact of an information campaign. Gastroenterol Clin Biol 2004; 28:714-719.
47. Buffington J, Damon S, Moyer L, Culver D. Racial differences in knowledge regarding hepatitis C virus infection. J Am Med Assoc 2000; 284:1651-1652.
48. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 1989; 27:S110-S127.
49. Barr DA, Wanat SF. Listening to patients: cultural and linguistic barriers to health care access. Fam Med 2005; 37:199-204.
50. Zickmund S, Hillis SL, Barnett MJ, Ippolito L, LaBrecque DR. Hepatitis C virus-infected patients report communication problems with physicians. Hepatology 2004; 39:999-1007.
51. Perez-Stable EJ, Napoles-Springer A, Miramontes JM. The effects of ethnicity and language on medical outcomes of patients with hypertension or diabetes. Med Care 1997; 35:1212-1219.
52. Green AR, Ngo-Metzger Q, Legedza AT, Massagli MP, Phillips RS, lezzoni LI. Interpreter services, language concordance, and health care quality. Experiences of Asian Americans with limited English proficiency. J Gen Intern Med 2005; 20:1050-1056.
53. Jacobs EA, Lauderdale DS, Meltzer D, Shorey JM, Levinson W, Thisted RA. Impact of interpreter services on delivery of health care to limited-English-proficient patients. J Gen Intern Med 2001; 16:468-474.
54. Zun LS, Sadoun T, Downey L. English-language competency of self-declared English-speaking Hispanic patients using written tests of health literacy. J Natl Med Assoc 2006; 98:912-917.
55. Jacobs E, Chen AH, Karliner LS, Agger-Gupta N, Mutha S. The need for more research on language barriers in health care: a proposed research agenda. Milbank Q 2006; 84:111-133.
56. Manson A. Language concordance as a determinant of patient compliance and emergency room use in patients with asthma. Med Care 1988; 26:1119-1128.
57. Ngo-Metzger Q, Massagli MP, Clarridge BR, Manocchia M, Davis RB, lezzoni LI, et al. Linguistic and cultural barriers to care. J Gen Intern Med 2003; 18:44-52.
58. Lee LJ, Batal HA, Maselli JH, Kutner JS. Effect of Spanish interpretation method on patient satisfaction in an urban walk-in clinic. J Gen Intern Med 2002; 17:641-645.
59. Morales LS, Elliott M, Weech-Maldonado R, Hays RD. The impact of interpreters on parents' experiences with ambulatory care for their children. Med Care Res Rev 2006; 63:110-128.